AbbVie: Strong 2026 Outlook, Expect Dividend Increases (NYSE:ABBV)

I publish my best ideas and top coverage on the Growth Stock Forum. If you're interested in finding great growth stocks, with a focus on biotech, consider signing up. We focus on attractive risk/reward situations and track each of our portfolio and watchlist stocks closely.Our biotech Top Picks increased 137.6% last year with a 35.3% CAGR since 2017, along with a 23.2% CAGR for our core portfolio LTGP (CAGR performance as of March 20, 2026).To receive e-mail notifications for my public articles and blogs, ...